Literature DB >> 14988580

Controlled contrast transcranial Doppler and arterial blood gas analysis to quantify shunt through patent foramen ovale.

Gérald Devuyst1, Bartlomiej Piechowski-Józwiak, Theodoros Karapanayiotides, Jean-William Fitting, Vendel Kémeny, Lorenz Hirt, Luis A Urbano, Pierre Arnold, Guy van Melle, Paul-Andre Despland, Julien Bogousslavsky.   

Abstract

BACKGROUND AND
PURPOSE: A right-to-left shunt can be identified by contrast transcranial Doppler ultrasonography (c-TCD) at rest and/or after a Valsalva maneuver (VM) or by arterial blood gas (ABG) measurement. We assessed the influence of controlled strain pressures and durations during VM on the right-to-left passage of microbubbles, on which depends the shunt classification by c-TCD, and correlated it with the right-to-left shunt evaluation by ABG measurements in stroke patients with patent foramen ovale (PFO).
METHODS: We evaluated 40 stroke patients with transesophageal echocardiography-documented PFO. The microbubbles were recorded with TCD at rest and after 4 different VM conditions with controlled duration and target strain pressures (duration in seconds and pressure in cm H2O, respectively): V5-20, V10-20, V5-40, and V10-40. The ABG analysis was performed after pure oxygen breathing in 34 patients, and the shunt was calculated as percentage of cardiac output.
RESULTS: Among all VM conditions, V5-40 and V10-40 yielded the greatest median number of microbubbles (84 and 95, respectively; P<0.01). A significantly larger number of microbubbles were detected in V5-40 than in V5-20 (P<0.001) and in V10-40 than in V10-20 (P<0.01). ABG was not sensitive enough to detect a shunt in 31 patients.
CONCLUSIONS: The increase of VM expiratory pressure magnifies the number of microbubbles irrespective of the strain duration. Because the right-to-left shunt classification in PFO is based on the number of microbubbles, a controlled VM pressure is advised for a reproducible shunt assessment. The ABG measurement is not sensitive enough for shunt assessment in stroke patients with PFO.

Entities:  

Mesh:

Year:  2004        PMID: 14988580     DOI: 10.1161/01.STR.0000119384.28376.EB

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

Review 1.  When and how to diagnose patent foramen ovale.

Authors:  F J Pinto
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

2.  Effect of a patent foramen ovale on pulmonary gas exchange efficiency at rest and during exercise.

Authors:  Andrew T Lovering; Michael K Stickland; Markus Amann; Matthew J O'Brien; John S Hokanson; Marlowe W Eldridge
Journal:  J Appl Physiol (1985)       Date:  2011-03-03

3.  Patent foramen ovale: the never-ending story.

Authors:  Gérald Devuyst; Julien Bogousslavsky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

4.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

5.  Estimation of patent foramen ovale size using transcranial Doppler ultrasound in patients with ischemic stroke.

Authors:  Anna Grisold; Walter Rinner; Anna Paul; Harald Gabriel; Uros Klickovic; Michael Wolzt; Martin Krenn; Fritz Zimprich; Gabriel Bsteh; Thomas Sycha
Journal:  J Neuroimaging       Date:  2021-09-30       Impact factor: 2.324

6.  Prevalence of patent foramen ovale in the Greek population is high and impacts on the interpretation of the risk of paradoxical embolism (RoPE) score.

Authors:  Ioanna Koutroulou; Georgios Tsivgoulis; Dimitris Karacostas; Ignatios Ikonomidis; Nikolaos Grigoriadis; Theodoros Karapanayiotides
Journal:  Ther Adv Neurol Disord       Date:  2020-10-10       Impact factor: 6.570

7.  Evaluation of patent foramen ovale in young adults with cryptogenic stroke.

Authors:  Hossein Ali Ebrahimi; Akbar Hamzeaie Moghadam; Esmaeel Aredestani
Journal:  ARYA Atheroscler       Date:  2011

8.  Transcranial Doppler ultrasonography should it be the first choice for persistent foramen ovale screening?

Authors:  Monika Komar; Maria Olszowska; Tadeusz Przewłocki; Jakub Podolec; Jakub Stępniewski; Bartosz Sobień; Rafał Badacz; Anna Kabłak-Ziembicka; Lidia Tomkiewicz-Pająk; Piotr Podolec
Journal:  Cardiovasc Ultrasound       Date:  2014-05-22       Impact factor: 2.062

Review 9.  Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review.

Authors:  Ioanna Koutroulou; Georgios Tsivgoulis; Dimitrios Tsalikakis; Dimitris Karacostas; Nikolaos Grigoriadis; Theodoros Karapanayiotides
Journal:  Front Neurol       Date:  2020-04-28       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.